Skip to search formSkip to main contentSkip to account menu

CI 978

Known as: CI-978 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

sparfloxacin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1990
1990
In vitro susceptibility of Mycobacterium avium complex to the new fluoroquinolone sparfloxacin (CI-978; AT-4140) and comparison with ciprofloxacin
We tested the activity of the new fluoroquinolone sparfloxacin (CI-978; AT 4140) against 30 strains of Mycobacterium avium… 
1990
1990
In vitro activity of sparfloxacin (CI-978; AT-4140) against clinical isolates from cancer patients
The in vitro activity of sparfloxacin, a new quinolone, was compared with those of ciprofloxacin and fleroxacin against gram… 
1990
1990
In vitro activity of sparfloxacin (AT-4140, CI-978, PD 131501), a new quinolone antimicrobial agent.
1990
1990
InVitro Activity ofSparfloxacin (CI-978; AT-4140) forClinical Legionella Isolates, Pharmacokinetics inGuinea Pigs, andUseTo Treat Guinea PigswithL.pneumophila Pneumonia
Theactivities ofsparfloxacin, ciprofloxacin, anderythromycin for21clinical Legionella isolates were determined… 
1990
1990
Comparative in vitro activity of the new quinolone sparfloxacin (CI-978, AT-4140) against nosocomial gram-negative bloodstream isolates
The in vitro activity of sparfloxacin (CI-978, AT-4140), a new quinolone which is active against gram-negative and gram-positive… 
1990
1990
Comparative InVitro Activities ofSparfloxacin (CI-978; AT-4140) andOtherAntimicrobial Agents against Staphylococci, Enterococci, andRespiratory TractPathogens
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)